Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axcess Global Sciences is a life sciences and intellectual property company focused on the development and licensing of metabolic health technologies, specifically exogenous ketones. The company holds the exclusive global rights to a significant portfolio of patents related to Beta-Hydroxybutyrate (BHB) salts and esters, originally developed through research at the University of South Florida. Their business model primarily involves licensing these proprietary ketogenic compounds to third-party brands in the nutraceutical, functional food, and medical nutrition industries. By enabling the induction of nutritional ketosis without strict dietary restrictions, Axcess Global Sciences' technologies target applications in weight management, athletic performance, and cognitive health. The company plays a central role in the commercial ketogenic supplement market through its extensive patent enforcement and partnership network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axcess Global Sciences.